Tullis — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)Amelia Degenkolb(Executive Officer, Director)
BoardLilly DeSouza Burr(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)
Board seatCurt LaBelle· per SEC Form D · $28M raise · filed Jul 2024
Co-investorsForeground CapitalLaerdal Million Lives Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.